Follow The Filings

HQY HealthEquity

HealthEquity earnings company data as of 4:50 AM ET 10/23

  • 0 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q4 2 Dec EPS 0.96 — —
Rev — — —
FY2027 Q2 27 Aug EPS 0.99 0.78 Miss -21.2%
Rev $349.2M $175.9M Miss -49.6%

Insider trades

Open-market buys and sales by HQY's executives, directors and 10% owners in the last 12 months, from their Form 4s

All HQY insider trades
  • $12K bought by 1 insider
  • $1.5M sold by 3 insiders outside a trading plan
  • $2.7M sold by 4 insiders under 10b5-1 plans
  1. Sunil Rajasekar EVP Chief Prod & Strat Officer
    Buy
    $12K 131 shares at $91.16 +0.2% to stake
    Traded Jul 8–Oct 15 Filed Oct 19
    ↗
  2. Sunil Rajasekar EVP Chief Prod & Strat Officer
    Sale
    $13K 131 shares at $101.60 0.2% of stake
    Traded Apr 22–Aug 24 Filed Oct 19
    ↗
  3. Adrian T Dillon Director
    Planned sale
    $798K 7,632 shares at $104.61 11% of stake
    Traded Aug 25 Filed Aug 27
    ↗
  4. Michael Henry Fiore EVP, Chief Commercial Officer
    Planned sale
    $224K 2,354 shares at $95.00 4.3% of stake
    Traded Jul 10 Filed Jul 14
    ↗
  5. Michael Henry Fiore EVP, Chief Commercial Officer
    Planned sale
    $235K 2,470 shares at $95.00 4.2% of stake
    Traded Jul 2 Filed Jul 7
    ↗
  6. Michael Henry Fiore EVP, Chief Commercial Officer
    Planned sale
    $298K 3,142 shares at $95.00 5% of stake
    Traded May 29 Filed Jun 2
    ↗
  7. Gayle Furgurson Wellborn Director
    Planned sale
    $220K 2,439 shares at $90.00 11% of stake
    Traded May 28 Filed Jun 1
    ↗
  8. Delano Ladd EVP, General Counsel
    Planned sale
    $675K 7,500 shares at $90.00 7.6% of stake
    Traded May 28 Filed Jun 1
    ↗
  9. Delano Ladd EVP, General Counsel
    Planned sale
    $142K 1,500 shares at $94.72 2% of stake
    Traded Dec 19, 2025 Filed Dec 23, 2025
    ↗
  10. Elimelech Rosner EVP, Chief Technology Officer
    Sale
    $1M 10,959 shares at $95.45 19% of stake
    Traded Dec 18, 2025 Filed Dec 19, 2025
    ↗
  11. Gayle Furgurson Wellborn Director
    Sale
    $425K 4,339 shares at $98.03 18% of stake
    Traded Dec 12, 2025 Filed Dec 16, 2025
    ↗
  12. Delano Ladd EVP, General Counsel
    Planned sale
    $157K 1,500 shares at $104.56 1.9% of stake
    Traded Nov 20, 2025 Filed Nov 24, 2025
    ↗
  13. Delano Ladd EVP, General Counsel
    Planned sale
    $138K 1,500 shares at $92.07 1.9% of stake
    Traded Oct 20, 2025 Filed Oct 22, 2025
    ↗
  14. Michael Henry Fiore EVP, Chief Commercial Officer
    Planned sale
    $157K 1,781 shares at $88.21 3.5% of stake
    Traded Oct 7, 2025 Filed Oct 8, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 27 share withholdings for taxes, 20 stock grants, 4 gifts, and 3 option exercises.

SEC filings

Recent issuer filings from EDGAR, 12 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
8-K 5.02 Filing Doc
8-K 5.02,7.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.